5Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal eytoreduetive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 2002, 20 : 1248-1259.
6Manci N, Bellati F, Muzii L, et aL Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data. Ann Surg Oncol, 2006,13 : 1717-1723.
7Spencer N J, Spencer JA, Perren TJ, et al. CT appearances and prognostic significance of splenic metastasis in ovarian cancer. Clin Radiol, 1998, 53:417-421.
8Ayhan A, Al RA, Baykal C, et al. The influence of splenic metastases on survival in FIGO stage Ⅲ c epithelial ovarian cancer. Int J Gynecol Cancer, 2004, 14: 51-56.
9Magtibay PM, Adams PB, Silverman MB, et al. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol, 2006,102:369-374.
10Nicklin JL, Copeland LJ, O'Toole RV, et al. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol, 1995, 58:244-247.
